Watson Labs Says Merck Contraceptive Patent Nixed By Sale
Watson Laboratories urged a Federal Circuit panel Tuesday to nix a ruling that its generic new drug application infringes a Merck patent for an ingredient used in Bayer Pharma AG's contraceptive...To view the full article, register now.
Already a subscriber? Click here to view full article